Retatrutide 5mg

Description

Retatrutide 5mg is a novel investigational peptide developed for research into multi-receptor agonism targeting weight management and metabolic regulation. Retatrutide is a triple agonist that activates the GLP-1, GIP, and glucagon receptors, making it a unique candidate for the study of glucose metabolism, appetite control, and energy expenditure. It is currently under investigation for its potential to support weight reduction and metabolic health through multiple hormonal pathways.

How it works
Retatrutide functions as a triple receptor agonist, simultaneously activating GLP-1, GIP, and glucagon receptors. This combined action is designed to promote glucose regulation, reduce appetite, increase energy expenditure, and enhance fat metabolism. By leveraging these synergistic effects, Retatrutide may provide a promising avenue for metabolic research and the study of obesity and related conditions.

Key benefits of Retatrutide 5mg:

• Supports appetite regulation
• Studied for weight management research
• Targets GLP-1, GIP, and glucagon receptors
• Promotes glucose metabolism
• Investigated for energy expenditure enhancement
• Supports fat metabolism studies

Usage and safety:

• Peptide Name: Retatrutide
• Quantity: 5mg
• Purity: ≥ 98%
• Form: Lyophilized powder
• Use: For laboratory research only. Not for human consumption.

Retatrutide 5mg is a research peptide designed to support metabolic and weight management studies by activating GLP-1, GIP, and glucagon receptors for multi-pathway hormonal regulation.

Disclaimer: This product is for research purposes only and is not intended for human or veterinary use.